The dysregulation of DNA repair and decreased apoptosis of RUNX1 mutant HSCs along with an increased inflammatory microenvironment may contribute to the markedly increased incidence of MDS, AML, and T-ALL in FPD/AML individuals. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.